The Latest Breaking News from MCK

June S&P 500 E-Mini futures (ESM24) are up +0.09%, and June Nasdaq 100 E-Mini futures (NQM24) are down -0.02% this morning after three major U.S. benchmark indices ended the regular session higher as recent U.S. jobs data and remarks from Federal Reserve officials buoyed rate-cut hopes while investors awaited further…

Given the growing demand for healthcare facilities, rapid integration of digital technology, and transformative biotechnology breakthroughs, the medical industry is poised for continued growth and profitability this year and beyond. Amid this, let’s find out why investors are flocking to medical stocks Vertex Pharmaceuticals (VRTX) and McKesson (MCK). Read more….

Techs led futures higher, with Palantir and Roku among the big earnings winners. Fed chief Jerome Powell signaled no more rate hikes, fueling Wednesday's strong market rally.

Cardinal Health and Cencora both broke out after topping earnings estimates as both drug-distributors got a boost from GLP-1 weight-loss drugs.

The Chart of the Day belongs to the healthcare company McKesson (MCK) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy signals, highest Weighted Alpha, superior current momentum and having a Trend Seeker buy signal then used the Flipchart feature...

Among the best stocks to buy and watch, drug giant McKesson is near a new buy point after Tuesday's stock market sell-off.

As the healthcare landscape becomes more well-equipped to meet the population’s medical needs, investors might benefit from buying A-rated medical stocks Addus HomeCare (ADUS), McKesson Corp (MCK), and Cardinal Health (CAH). Read on….

McKesson shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 74 to 81.

Stocks that stop working don't often get much room in swing trading.